- 全部删除
 
您的购物车当前为空
Vobramitamab (AEX-4089)是一种靶向B7-H3抗原(CD276)的人源化单克隆抗体,通过酶切肽链连接子与前驱药物seco-杜卡霉素羟基苯胺氮杂吲哚(seco-DUBA)偶联,形成研究性抗体-药物偶联物MGC018。

为众多的药物研发团队赋能,
让新药发现更简单!
Vobramitamab (AEX-4089)是一种靶向B7-H3抗原(CD276)的人源化单克隆抗体,通过酶切肽链连接子与前驱药物seco-杜卡霉素羟基苯胺氮杂吲哚(seco-DUBA)偶联,形成研究性抗体-药物偶联物MGC018。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 3,290  | In stock | |
| 5 mg | ¥ 7,260  | In stock | |
| 10 mg | ¥ 9,790  | In stock | |
| 25 mg | ¥ 14,500  | In stock | |
| 50 mg | ¥ 19,600  | In stock | 
Vobramitamab 相关产品
| 产品描述 | Vobramitamab (AEX-4089) is a humanized monoclonal antibody (mAb) targeting the B7-H3 antigen (CD276) which is conjugated to the prodrug seco-duocarmycin hydroxybenzamide azaindole (seco-DUBA) through a enzymatically cleavable peptide-based linker, thereby creating the investigational antibody-drug conjugate (ADC) known as MGC018.  | 
| 靶点活性 |  NB cell lines:17.8-364 ng/mL (IC50)  | 
| 别名 | 沃瑞妥单抗, AEX-4089, AEX4089 | 
| CAS No. | 2490556-50-6 | 
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容